ASH 2012: Experimental Ibrutinib Promotes High Response Rate in Leukemia

To contact us Click HERE
Here are interviews with my doctor, Dr. John Byrd from OSU and Dr. Claire Dearden from the UK after the press conference announcing the news on ibrutinib.

I will be following up with more videos and text a that provide more details, but this is a nice overview of the enthusiasm with this BTK inhibitor.

The video is from Internal Medicine News with thanks and that tells you that the interest in this therapy extends beyond the hematology community.



http://youtu.be/LmyNurcH7JA?t=16s